Aspirin could more than double the survival chances of women with breast cancer, according to a new study.Women who took aspirin after a diagnosis of breast cancer were 58 percent less likely to die in the following years, a Glasgow University study found.The study subjects took a low dose of "baby" aspirin.View: Celebrities who battled cancerThe study involved 4,627 women diagnosed with breast cancer around Dundee, Scotland between 1998 and 2008.Writing in the British Journal of Cancer, researcher Colin McCowan said aspirin may help by blocking inflammatory chemicals that fuel the growth of the disease.McCowan said more research is needed to see if the drug helps some women more than others.

Aspirin could more than double the survival chances of women with breast cancer, according to a new study.

Women who took aspirin after a diagnosis of breast cancer were 58 percent less likely to die in the following years, a Glasgow University study found.


The study subjects took a low dose of "baby" aspirin.

View: Celebrities who battled cancer

The study involved 4,627 women diagnosed with breast cancer around Dundee, Scotland between 1998 and 2008.

Writing in the British Journal of Cancer, researcher Colin McCowan said aspirin may help by blocking inflammatory chemicals that fuel the growth of the disease.

McCowan said more research is needed to see if the drug helps some women more than others.